The Assessment Core has three major goals. The first is to ascertain approximately 150 new participants for the studies being conducted by all of the Subprojects within this next phase of our Program Project. The ascertainment process will include coordinating human participant reviews at the New York State Institute or Basic Research in Developmental Disabilities (IBR), as well as obtaining informed consent for new participants. We will also obtain new informed consents for the approximately 150 participants from our previous studies that will be continuing enrollment in our program, and an additional group of 20 - 30 younger adults with Down syndrome who will be studied in Subproject 3. The second major goal of the Core is to coordinate and conduct comprehensive assessments of our 300 study participants in close collaboration with investigators within Subprojects 1, 2, 3 and 4. Our third goal, in close collaboration with Subproject 1, 2, 3, 4 and the Genetics Core, will be to collect blood samples from program participants for analyses of biomarkers, genotype and epigenetic studies of methylation. The fourth goal will be to enter data from assessments into our Core database to facilitate analyses by Program Subprojects, and to maintain a separate participant tracking database. These activities will ensure that all Program participants are characterized using standardized procedures and common measures, providing rich descriptions of phenotype, facilitating analyses within individual Subprojects, and supporting interactions among Subprojects.

National Institute of Health (NIH)
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Research Program Projects (P01)
Project #
Application #
Study Section
Special Emphasis Panel (ZHD1-MRG-C)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Hugo W. Moser Research Institute Kennedy Krieger
United States
Zip Code
Krinsky-McHale, Sharon J; Silverman, Wayne; Gordon, James et al. (2014) Vision deficits in adults with Down syndrome. J Appl Res Intellect Disabil 27:247-63
Janicki, S C; Park, N; Cheng, R et al. (2014) Estrogen receptor ? variants affect age at onset of Alzheimer's disease in a multiethnic female cohort. Dement Geriatr Cogn Disord 38:200-13
Janicki, S C; Park, N; Cheng, R et al. (2013) Aromatase variants modify risk for Alzheimer's disease in a multiethnic female cohort. Dement Geriatr Cogn Disord 35:340-6
Krinsky-McHale, Sharon J; Silverman, Wayne (2013) Dementia and mild cognitive impairment in adults with intellectual disability: issues of diagnosis. Dev Disabil Res Rev 18:31-42
Silverman, Wayne P; Zigman, Warren B; Krinsky-McHale, Sharon J et al. (2013) Intellectual Disability, Mild Cognitive Impairment, and Risk for Dementia. J Policy Pract Intellect Disabil 10:
Xing, Luzhou; Salas, Martha; Zhang, Hong et al. (2013) Creation and characterization of BAC-transgenic mice with physiological overexpression of epitope-tagged RCAN1 (DSCR1). Mamm Genome 24:30-43
Zigman, Warren B (2013) Atypical aging in Down syndrome. Dev Disabil Res Rev 18:51-67
Esbensen, Anna J; Mailick, Marsha R; Silverman, Wayne (2013) Long-term impact of parental well-being on adult outcomes and dementia status in individuals with Down syndrome. Am J Intellect Dev Disabil 118:294-309
Chace, Constance; Pang, Deborah; Weng, Catherine et al. (2012) Variants in CYP17 and CYP19 cytochrome P450 genes are associated with onset of Alzheimer's disease in women with down syndrome. J Alzheimers Dis 28:601-12
Prasher, V P; Sajith, S G; Mehta, P et al. (2010) Plasma beta-amyloid and duration of Alzheimer's disease in adults with Down syndrome. Int J Geriatr Psychiatry 25:202-7

Showing the most recent 10 out of 60 publications